Defining an optimal regimen for cytomegalovirus prophylaxis in organ transplant recipients.
Paya
C V
CV
Mayo Clinic, Rochester, Minnesota 55905, USA.
D000998:Antiviral Agents / Q000627:therapeutic use; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D016377:Organ Transplantation; D014611:Vaccination
D000998:Antiviral Agents; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin